CTI BIOPHARMA - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 86359462
Serial Number
86359462
Registration Number
5715670
Word Mark
CTI BIOPHARMA
Status
700 - Registered
Status Date
2019-04-02
Filing Date
2014-08-06
Registration Number
5715670
Registration Date
2019-04-02
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) Typeset
Design Searches
020133, 040703, 260121, 261709 - Grotesque men formed by letters, numbers, punctuation or geometric shapes. Geometric figures or combinations of geometric figures representing a person. Circles that are totally or partially shaded. Curved line(s), band(s) or bar(s).
Published for Opposition Date
2015-12-01
Attorney Name
Frances M. Jagla
Law Office Assigned Location Code
L70
Employee Name
LEE, YAT SYE I
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Disclaimer with Predetermined Text
"BIOPHARMA"
Description of Mark
The mark consists of a stylized image of a stick figure design to the left hand side of the wording "CTI BIOPHARMA".
Goods and Services
Pharmaceutical preparations and substances for the treatment of cancer and for use in chemotherapy treatment; Pharmaceutical preparations and substances for the treatment of immunological, oncological, inflammatory and infectious diseases and disorders; Pharmaceutical preparations used for the treatment of conditions secondary to the oncologic, immunological and inflammatory diseases; Pharmaceutical preparations and substances for the management and treatment of pain accompanying either the disease process or the associated treatment regimens
Goods and Services
Conducting seminars, classes, workshops, and training in the fields of pharmaceutical products and the treatment of medical disorders, the life sciences, clinical trials, health, medicine, oncology, hematology, cancer, and genetic disorders, and providing course materials in connection therewith; Online publications in the nature of articles, journals, and newsletters in the fields of pharmaceuticals and the treatment of medical disorders, the life sciences, clinical trials, health, medicine, oncology, hematology, cancer, and genetic disorders
Goods and Services
Research, development, engineering, testing, product evaluation, and inspection in the field of pharmaceutical preparations and products; pharmaceutical research and development; providing technical consultation in the field of pharmaceutical product research and development; medical and scientific research, namely, conducting clinical trials for others for pharmaceutical preparations used for the treatment of cancer, immunological, inflammatory and infectious diseases, and pain; scientific research, consulting, and advice in the fields of biotechnology, pharmaceutical research and development, and the life sciences; pharmaceutical, medical and laboratory research services in the fields of pharmaceuticals, cancer, genetic disorders, and the life sciences; providing medical testing services for research purposes and medical and scientific research information in the fields of pharmaceuticals, the life sciences, clinical trials, medicine, oncology, hematology, cancer, disease classification, and genetic disorders; and consultation related to the foregoing
Classification Information
International Class
041 - Education; providing of training; entertainment; sporting and cultural activities. - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes
100, 101, 107
Class Status Code
6 - Active
Class Status Date
2014-08-15
Primary Code
041
First Use Anywhere Date
2014-06-21
First Use In Commerce Date
2014-06-21
Current Trademark Owners
Party Name
CTI BIOPHARMA CORP.
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
CTI BIOPHARMA CORP.
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
CTI BIOPHARMA CORP.
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
CTI BIOPHARMA CORP.
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Frances M. Jagla
Address
Please log in with your Justia account to see this address.
Prior Registrations
Relationship TypeReel Number
Prior Registration2854845
Continuity Child86978798
Trademark Events
Event DateEvent Description
2014-08-09NEW APPLICATION ENTERED IN TRAM
2014-08-15NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2014-08-16NOTICE OF DESIGN SEARCH CODE E-MAILED
2014-08-31ASSIGNED TO EXAMINER
2014-08-31NON-FINAL ACTION WRITTEN
2014-08-31NON-FINAL ACTION E-MAILED
2014-08-31NOTIFICATION OF NON-FINAL ACTION E-MAILED
2015-02-25TEAS RESPONSE TO OFFICE ACTION RECEIVED
2015-03-05ASSIGNED TO LIE
2015-03-12CORRESPONDENCE RECEIVED IN LAW OFFICE
2015-03-12TEAS/EMAIL CORRESPONDENCE ENTERED
2015-04-29FINAL REFUSAL WRITTEN
2015-04-29FINAL REFUSAL E-MAILED
2015-04-29NOTIFICATION OF FINAL REFUSAL EMAILED
2015-10-19TEAS REQUEST FOR RECONSIDERATION RECEIVED
2015-10-19CORRESPONDENCE RECEIVED IN LAW OFFICE
2015-10-20TEAS/EMAIL CORRESPONDENCE ENTERED
2015-10-26APPROVED FOR PUB - PRINCIPAL REGISTER
2015-10-29LAW OFFICE PUBLICATION REVIEW COMPLETED
2015-11-11NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2015-12-01PUBLISHED FOR OPPOSITION
2015-12-01OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2016-01-26NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2016-02-23TEAS REQUEST TO DIVIDE RECEIVED
2016-04-12CASE ASSIGNED TO INTENT TO USE PARALEGAL
2016-02-23DIVISIONAL REQUEST RECEIVED
2016-04-14DIVISIONAL PROCESSING COMPLETE
2016-04-15CORRECTED NOA E-MAILED
2016-05-06TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2016-05-06ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2016-07-22TEAS EXTENSION RECEIVED
2016-07-22EXTENSION 1 FILED
2016-07-22EXTENSION 1 GRANTED
2016-07-26NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2017-01-25TEAS EXTENSION RECEIVED
2017-01-25EXTENSION 2 FILED
2017-01-25EXTENSION 2 GRANTED
2017-01-27NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2017-07-24TEAS EXTENSION RECEIVED
2017-07-24EXTENSION 3 FILED
2017-07-24EXTENSION 3 GRANTED
2017-07-26NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2017-12-05TEAS EXTENSION RECEIVED
2017-12-05EXTENSION 4 FILED
2017-12-05EXTENSION 4 GRANTED
2017-12-07NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2018-06-21TEAS EXTENSION RECEIVED
2018-06-21EXTENSION 5 FILED
2018-07-02EXTENSION 5 GRANTED
2018-07-03NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2019-01-28TEAS STATEMENT OF USE RECEIVED
2019-01-28USE AMENDMENT FILED
2019-02-04STATEMENT OF USE PROCESSING COMPLETE
2019-02-26ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
2019-02-27NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
2019-04-02REGISTERED-PRINCIPAL REGISTER
2020-05-06TEAS CHANGE OF OWNER ADDRESS RECEIVED
2020-05-06TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2020-05-06ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2020-05-06TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
2020-05-06TEAS CHANGE OF CORRESPONDENCE RECEIVED
2020-05-06APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
2020-05-14TEAS CHANGE OF OWNER ADDRESS RECEIVED
2020-05-14TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2020-05-14ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2020-05-14TEAS CHANGE OF CORRESPONDENCE RECEIVED
2020-05-14APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
2020-06-12REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED